Hims & Hers continues expanding internationally and strengthening its core healthcare platform beyond longevity therapies.

One prioritizes rapid consumer growth and profitability; the other commands scale but faces concentration risk.

The ad, which aired during the Super Bowl over the weekend, promoted a new product by Hims & Hers, a blood test designed to detect over 50 types of cancer before symptoms appear. This includes hard-to ...

Hims & Hers Health (HIMS 2.05%), the consumer-focused telehealth platform, closed Tuesday at $29.76, down 4.03%. The stock declined during the regular session after Amazon (AMZN +0.40%) launched a ...

Hims & Hers Health, Inc. is facing existential risk as regulatory uncertainty and margin erosion undermine its growth narrative. HIMS' reliance on compounded GLP-1 drugs has faltered, with regulatory ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Hims and Hers' 2026 Super Bowl ad, "Rich Peiole Live Longer" focused on the health-wealth ...

Few people consult a doctor before attempting weight loss. Hims offers virtual weight loss support for men, including consultations and prescriptions. Hims provides GLP-1 injections, meal replacements ...

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Hims & Hers Benefits, a new way for subscribers to access the best ...

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, payers and other industry ...

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, is adding five new members to its Medical Advisory Board. The group of specialists advises the company ...